Caisse de depot et placement du Quebec bought a new position in Itron, Inc. (NASDAQ:ITRI - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 17,400 shares of the scientific and technical instruments company's stock, valued at approximately $1,506,000.
Other large investors also recently made changes to their positions in the company. Capital World Investors acquired a new stake in Itron in the 4th quarter valued at approximately $10,460,000. Assenagon Asset Management S.A. lifted its holdings in Itron by 160.4% in the second quarter. Assenagon Asset Management S.A. now owns 336,710 shares of the scientific and technical instruments company's stock worth $29,136,000 after purchasing an additional 207,416 shares during the period. DNB Asset Management AS bought a new position in Itron in the 4th quarter valued at about $12,191,000. WINTON GROUP Ltd bought a new position in Itron in the 4th quarter valued at about $5,795,000. Finally, Fieldview Capital Management LLC increased its stake in Itron by 54.1% during the 4th quarter. Fieldview Capital Management LLC now owns 40,095 shares of the scientific and technical instruments company's stock valued at $3,723,000 after buying an additional 14,079 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.
Insider Buying and Selling at Itron
In other Itron news, CFO Joan S. Hooper sold 455 shares of the firm's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $98.79, for a total value of $44,949.45. Following the completion of the transaction, the chief financial officer directly owned 118,440 shares in the company, valued at $11,700,687.60. This trade represents a 0.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 283 shares of the firm's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $99.99, for a total transaction of $28,297.17. Following the completion of the transaction, the senior vice president owned 27,662 shares of the company's stock, valued at approximately $2,765,923.38. The trade was a 1.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 7,693 shares of company stock valued at $759,475. 1.77% of the stock is currently owned by corporate insiders.
Itron Price Performance
Shares of NASDAQ:ITRI opened at $97.53 on Friday. Itron, Inc. has a one year low of $77.77 and a one year high of $142.00. The stock has a fifty day moving average of $92.32 and a 200-day moving average of $90.08. The company has a market capitalization of $4.27 billion, a PE ratio of 16.28, a price-to-earnings-growth ratio of 1.17 and a beta of 1.30. The company has a debt-to-equity ratio of 0.96, a quick ratio of 2.29 and a current ratio of 2.75.
Itron (NASDAQ:ITRI - Get Free Report) last issued its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.29 by $0.30. Itron had a return on equity of 19.26% and a net margin of 11.90%.The business had revenue of $562.90 million for the quarter, compared to analysts' expectations of $566.34 million. During the same period in the previous year, the firm posted $1.62 EPS. The company's quarterly revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. As a group, equities analysts anticipate that Itron, Inc. will post 6.41 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts have issued reports on ITRI shares. Stephens reaffirmed an "overweight" rating and set a $130.00 price target on shares of Itron in a research note on Wednesday, May 20th. Zacks Research upgraded Itron from a "hold" rating to a "strong-buy" rating in a report on Thursday. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Itron in a report on Wednesday, August 5th. Seaport Research Partners reissued a "buy" rating and issued a $150.00 price target on shares of Itron in a report on Wednesday, July 29th. Finally, Robert W. Baird set a $125.00 price objective on shares of Itron in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $131.33.
View Our Latest Report on ITRI
Itron Company Profile
(
Free Report)
Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.